Kellogg earns grant from Research to Prevent Blindness
The funds will be deployed at the discretion of Paul P. Lee, M.D., JD, department chair.
Kellogg holds one of 38 RPB unrestricted grants nationwide. The grants are designed to provide maximum flexibility in developing and expanding eye research programs and provide opportunities for creative planning that go beyond the scope of restricted project grants.
From the early detection of childhood eye disorders through age-related diseases such as macular degeneration and diabetic retinopathy, the Kellogg Eye Center is a global leader in vision research.
Its RPB-funded work has resulted in a preliminary patent for new methods to remove microvessels that threaten sight. With support from RPB, Kellogg researchers envision the use of telemedicine to make care more available and accessible, no matter where patients live.
This unrestricted grant for Kellogg has been awarded based on a thorough review of criteria, including the department’s research activities, laboratory equipment, and clinical and scientific staff, as evaluated by RPB’s renowned Scientific Advisory Panel.
Since it was founded in 1960, RPB has channeled more than $345 million into eye research.